IndraLab
Statements
reach
"Additionally, LDN57444 pretreatment reduced the protein levels of IkappaBalpha, the negative NF-kappaB modulator, while overexpression of UCHL1 maintained IkappaBalpha levels, suggesting that UCHL1 promoted the stability of IkappaBalpha, which may further inhibit NF-kappaB activation in MSCs."